紫癜性肾炎患儿血清PTX3、IgA/C3水平变化及与肾功能损伤的相关性

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (688 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨紫癜性肾炎(purpuric nephritis,HSPN)患儿血清正五聚素-3(PTX3)、IgA/C3水平变化及与肾功能损伤的相关性。方法选择医院2014-05至2019-06收治的96例经吗替麦考酚酯与泼尼松联合治疗的HSPN患儿为治疗组,并选取同期来该院体检的80例健康儿童为对照组。观察两组受试者血清免疫球蛋白A(Ig A)、免疫球蛋白G(Ig G)、免疫球蛋白M(Ig M)、补体C3及PTX3水平变化,并计算IgA/C3值,比较两组受试者血清IgA/C3水平及肾功能指标差异,并通过Pearson法对经吗替麦考酚酯与泼尼松联合治疗的HSPN血清PTX3、IgA/C3水平与肾功能损伤的相关性进行分析。结果治疗组血清IgA、PTX3、IgA/C3、SCr水平明显高于对照组,血清IgG、IgM、eGFR、α-MG水平明显低于对照组(P<0.05)。经Pearson相关性分析,血清IgA/C3、PTX3水平均与血清SCr水平呈正相关,与血清eGFR、α-MG水平呈负相关(P<0.05)。结论经吗替麦考酚酯与泼尼松联合治疗后,HSPN患儿血清PTX3、IgA/C3水平均得到一定程度改善,且与肾功能损伤呈正相关。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	周彬
	党小宁
	傅忠国
	曹海妮
	杨莉红

关键词 ：吗替麦考酚酯, 泼尼松, 紫癜性肾炎, PTX3, IgA/C3, 肾功能, 相关性

Abstract：Objective To explore the changes of serum pentamerin-3 (PTX3) and IgA/C3 levels in patients with purpuric nephritis and their correlations with renal damage. Methods The 96 patients with purpuric nephritis treated with mycophenolate mofetil combined with prednisone treated in our hospital between May 2014 and June 2019 were selected as the treatment group while another 80 healthy physical examinees in the same period were selected as the control group. The changes of serum levels of immunoglobulin A (IgA), immunoglobulin G (IgG), immunoglobulin M (IgM), complement C3 (C3) and PTX3 in the two groups were observed. The IgA/C3 value was calculated, while the difference in serum IgA/C3 levels and renal function indexes was compared between the two groups. The Pearson method was used to analyze the correlations between serum PTX3, IgA/C3 levels and renal impairment in patients with purpuric nephritis treated with mycophenolate mofetil combined with prednisone. Results Serum levels of IgA, PTX3, IgA/C3, and SCr in the treatment group were significantly higher than those of the control group, but serum IgG, IgM, eGFR, and α-MG levels were significantly lower (P<0.05). Pearson correlation analysis showed that serum IgA/C3 and PTX3 levels were positively correlated with serum SCr levels, but negatively with serum eGFR and α-MG levels (P<0.05). Conclusions After combined treatment with mycophenolate mofetil and prednisone, the serum PTX3 and IgA/C3 levels of patients with purpuric nephritis have been improved to some extent, and they are positively correlated with renal function damage.

Key words： mycophenolate mofetil combined with prednisone purpuric nephritis PTX3 IgA/C3 renal function correlation

收稿日期: 2020-08-10

ZTFLH:

R556.6

作者简介: 周彬,硕士,副主任医师。

引用本文:

周彬, 党小宁, 傅忠国, 曹海妮, 杨莉红. 紫癜性肾炎患儿血清PTX3、IgA/C3水平变化及与肾功能损伤的相关性[J]. 武警医学, 2021, 32(3): 193-196. ZHOU Bin, DANG Xiaoning, FU Zhongguo, CAO haini, YANG Lihong. Changes of serum PTX3 and IgA/C3 levels in patients with Henoch Schonlein purpura nephritis treated with mycophenolate mofetil and prednisone. Med. J. Chin. Peop. Armed Poli. Forc., 2021, 32(3): 193-196.

链接本文:

http://journal08.magtechjournal.com/Jwk_wjyx/CN/ 或 http://journal08.magtechjournal.com/Jwk_wjyx/CN/Y2021/V32/I3/193

[1]	Hiroyuki T, Hiroshi M. Henoch schönlein purpura nephritis associated with intravesical bacillus calmette-guerin (bcg) therapy[J]. Intern Med, 2017, 56(5):541-544.
[2]	赵慧, 殷健. 消化道穿孔为主要表现的过敏性紫癜1例[J]. 武警医学, 2019, 30(1):70-71.
[3]	杜川,董璇,陈铖,等.儿童紫癜性肾炎244例的流行病学特征与肾脏受累危险因素分析[J].西部医学,2017,29(9):1268-1271.
[4]	邢静, 李文斌, 王艳飞,等. 儿童过敏性紫癜血清IL-21、TGF-β1、TNF-α、IgA1的变化与紫癜性肾炎发生的相关性研究[J]. 基因组学与应用生物学, 2017,20(7):2633-2639.
[5]	李锦芬,李晓忠.血清胱抑素C纤维蛋白原及24小时尿蛋白定量对紫癜性肾炎儿童肾损伤程度的评估效果[J].安徽医学,2018,39(2):186-188.
[6]	Jean D D, Julien H, Bilal A, et al. Clinical outcomes in children with henoch-sch?nlein purpura nephritis without crescents[J]. Pediatr Nephrol, 2017, 32(7):1193-1199.
[7]	朱春华, 黄松明. 紫癜性肾炎诊治循证指南(2016)解读[J]. 中华儿科杂志, 2017, 55(9):654-657.
[8]	Kasahara K, Gotoh Y, Kuroyanagi Y, et al.Warfarin-induced toxic epidermal necrolysis in combination therapy of henoch-sch nlein purpura nephritis: a case report[J]. Bmc Nephrol, 18(1):237-245.
[9]	Zhao S, Shen H, Gu W, et al. Evaluation of TGF-β1 and MCP-1 expression and tubulointerstitial fibrosis in children with Henoch-Schönlein purpura nephritis and IgA nephropathy: a clinical correlation[J]. Clinics, 2017, 72(2):95-102.
[10]	Huang Xiao, Wu Xiaomei, Le Weibo, et al. Renal prognosis and related risk factors for henoch-schnlein purpura nephritis: a chinese adult patient cohort[J]. Sci Rep, 2001,8(1):5585-5596.
[11]	Wang J, Li Y, Chen Y, et al. Urinary macrophage migration inhibitory factor as a noninvasive biomarker in pediatric henoch-schnlein purpura nephritis[J]. J Clin Rheumatol, 2001,23(5):258-261.
[12]	Deng Z, Yang Z, Ma X, et al. Urinary metal and metalloid biomarker study of Henoch-Schonlein purpura nephritis using inductively coupled plasma orthogonal acceleration time-of-flight mass spectrometry[J]. Talanta, 2018, 178(6):728-735.
[13]	姜维. 泼尼松联合吗替麦考酚酯治疗对难治性肾病综合征患者细胞免疫功能及细胞因子的影响[J]. 中国医师杂志,2017,19(5): 742-744.
[14]	张建江, 贾莉敏, 史佩佩,等. 吗替麦考酚酯联合糖皮质激素治疗儿童紫癜性肾炎的疗效观察[J]. 中华肾脏病杂志, 2017, 33(9):670-677.
[15]	Sedhain A, Hada R, Agrawal R K, et al. Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial[J]. Bmc Nephrol, 2018,19(1):175-183.
[16]	刘梅, 王军, 孙红, 等. 过敏性紫癜与紫癜性肾炎患儿免疫功能的比较及临床意义探讨[J]. 检验医学与临床, 2019,16(8):58-61.
[17]	Min Tan, Jing Fang, Qianqian Xu, et al. Outcomes of normotensive IgA nephropathy patients with mild proteinuria who have impaired renal function[J]. Renal Failure, 2019, 41(1):875-882.
[18]	Yuan M, Tan Y, Pang Y, et al. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study[J]. Ren Fail, 2017, 39(1):465-473.